... - Event to Be Webcast June 12 at 5:15 p.m. Eastern Time - -... Surgery Annual Meeting - ...REDWOOD CITY Calif. June 9 /- Cardica Inc.(...The Company also announced that data from the 220-patient prospective...

- Event to Be Webcast June 12 at 5:15 p.m. Eastern Time -
- PAS-Port(R) System Clinical Data To Be Presented During Late Breaking
News Session of International Society for Minimally Invasive Cardiothoracic

Surgery Annual Meeting -

REDWOOD CITY, Calif., June 9 /PRNewswire-FirstCall/ -- Cardica, Inc.
(Nasdaq: CRDC) today announced that it will webcast an investor briefing on
the topic of "Revolutionizing Revascularization" on Thursday, June 12, at
5:15 p.m. Eastern Time in Boston. The event will feature a panel of
renowned cardiovascular surgeons who will discuss how surgeons are
integrating new techniques to improve coronary artery bypass graft (CABG)
procedures, including the use of Cardica's C-Port(R) Distal Anastomosis
Systems, which are designed to allow surgeons to automate the attachment of
blood vessel grafts during CABG procedures, replacing traditional hand-sewn
sutures.

The Company also announced that data from the 220-patient prospective,
randomized pivotal clinical trial of its PAS-Port(R) Proximal Anastomosis
System will be presented at the 2008 Annual Scientific Meeting of the
International Society for Minimally Invasive Cardiothoracic Surgery
(ISMICS) in Boston. The presentation, entitled "The Cardica PAS-Port
Proximal Anastomotic Connector Device: First Report of the Results of the
FDA Trial," will be given during the Late Breaking News session on
Thursday, June 12, at 1:15 p.m. Eastern Time by principal study
investigator John D. Puskas, M.D., chief of cardiac surgery at Emory
Crawford Long Hospital in Atlanta. As previously announced, the trial,
which compared graft vessel connections made using the PAS-Port system to
conventional hand-sewn sutures during CABG procedures, achieved all of its
primary and secondary endpoints. Based on the positive trial data, Cardica
submitted a 510(k) premarket notification in April to the U.S. Food and
Drug Administration for the PAS-Port system.
Panelists for the investor event will include:

-- Husam H. Balkhy, M.D., chairman of cardiothoracic surgery at The

Wisconsin Heart Hospital and clinical assistant professor of surgery at

the Medical College of Wisconsin. He is a well-known advocate of

minimally-invasive cardiac surgery and has the largest experience in

the United States with distal anastomotic devices in coronary artery

bypass.

-- Robert S. Poston, M.D., chief of cardiac surgery at Boston Medical

Center. Previously, he was an associate professor of surgery at the

University of Maryland where he focused his activities in the field of

off-pump and minimally-invasive/robotic CABG. His research into

minimally-invasive CABG and the hybrid procedure was recognized in 2005

The event will be webcast live on Thursday, June 12, at 5:15 p.m.
Eastern Time. To access the live and subsequently archived webcast of the
discussion, go to the Investor Relations section of Cardica's website at
http://www.cardica.com. Please connect to the website at least 15 minutes
prior to the webcast to allow for any necessary software downloads.

About Cardica

Cardica is a leading provider of automated anastomosis systems for
coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures
with easy-to-use automated systems, Cardica's products provide
cardiovascular surgeons with rapid, reliable and consistently reproducible
anastomoses, or connections of blood vessels, often considered the most
critical aspect of the CABG procedure. Cardica's C-Port(R) Distal
Anastomosis Systems are marketed in Europe and the United States. The
PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan,
and Cardica has submitted a 510(k) premarket notification for clearance to
market the PAS-Port system in the United States. Cardica also is developing
additional devices with Cook Medical to facilitate vascular closure and
other surgical procedures.

(Date:12/8/2016)... 8, 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...

(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...

(Date:12/8/2016)... Dec. 8, 2016 Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...

(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...

(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...

(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...

(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...